FDA Authorizes New High-Throughput, Automated System for Leading COVID-19 Test
Thermo Fisher Scientific Inc. the world leader in serving science, today announced that the U.S. Food and Drug Administration has granted Emergency Use Authorization for the Thermo Fisher Scientific Amplitude Solution with the TaqPath COVID-19 High-Throughput Combo Kit. The Amplitude Solution enables clinical and public health laboratories to scale gold standard PCR testing and process up to 8,000 samples in a …
– Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for the Thermo Fisher Scientific Amplitude Solution with the TaqPath COVID-19 High-Throughput Combo Kit.
FDA Authorizes New High-Throughput, Automated System for Leading COVID-19 Test prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Thermo Fisher unveils high-throughput solution to test 8k COVID-19 samples daily
Thermo Fisher unveils high-throughput solution to test 8k COVID-19 samples daily
09 February 2021 | News
Source credit: Shutterstock
Thermo Fisher Scientific, the world leader in serving science, launched its CE-IVD-Marked, Applied Biosystems TaqPath COVID–19 HT Kit that is compatible with the Amplitude platform. The high-throughput solution enables clinical and public health laboratories to efficiently test up to 8,000 COVID-19 samples a day with fewer staffing requirements and a reliable supply of kits, reagents and consumables.
The highly automated Amplitude platform is a molecular diagnostic system that allows labs to increase their COVID-19 testing capacity by combining Thermo Fisher s extraction and real-time PCR instruments with liquid handling products from Tecan Group. The system leverages a high-throughput version of Thermo Fisher s TaqPath COVID-19 CE-IVD RT-PCR Kit, which received
Share this article
Share this article
CARLSBAD, Calif., Feb. 8, 2021 /PRNewswire/ Thermo Fisher Scientific, the world leader in serving science, today launched its CE-IVD-Marked, Applied Biosystems TaqPath COVID–19 HT Kit that is compatible with the Amplitude platform. The high-throughput solution enables clinical and public health laboratories to efficiently test up to 8,000 COVID-19 samples a day with fewer staffing requirements and a reliable supply of kits, reagents and consumables.
The highly automated Amplitude platform is a molecular diagnostic system that allows labs to increase their COVID-19 testing capacity by combining Thermo Fisher s extraction and real-time PCR instruments with liquid handling products from Tecan Group. The system leverages a high-throughput version of Thermo Fisher s TaqPath COVID-19 CE-IVD RT-PCR Kit, which received CE-IVD Mark in March 2020.